|
Market Closed -
Other stock markets
|
After hours 07:59:50 pm | |||
| 74.66 USD | +0.61% |
|
73.42 | -1.66% |
| Jul. 07 | UBS Adjusts Price Target on Altria Group to $79 From $76 | MT |
| Jun. 26 | Philip Morris, Other Tobacco Stocks Rise After FDA Proposes Foreign Tobacco Regulations | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 17.3 | 20.11 | 20.19 | 26.38 | 27.32 | |||||
Return on Total Capital | 25.54 | 31.26 | 33.51 | 42.77 | 42.63 | |||||
Return On Equity % | 364.24 | -208.5 | -219.34 | -396.76 | -246.35 | |||||
Return on Common Equity | 399.68 | -206.17 | -215.97 | -388.92 | -241.36 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 66.03 | 68.56 | 69.53 | 87.06 | 87.34 | |||||
SG&A Margin | 9.04 | 9.1 | 10.04 | 10.94 | 11.15 | |||||
EBITDA Margin % | 58.14 | 60.55 | 60.82 | 77.51 | 77.51 | |||||
EBITA Margin % | 57.33 | 59.81 | 60.12 | 76.8 | 76.85 | |||||
EBIT Margin % | 56.99 | 59.46 | 59.49 | 76.12 | 76.19 | |||||
Income From Continuing Operations Margin % | 11.72 | 27.86 | 39.65 | 55.1 | 34.5 | |||||
Net Income Margin % | 11.72 | 27.86 | 39.65 | 55.1 | 34.5 | |||||
Net Avail. For Common Margin % | 11.67 | 27.8 | 39.57 | 54.96 | 34.4 | |||||
Normalized Net Income Margin | 14.5 | 22.98 | 34.94 | 46.4 | 45.86 | |||||
Levered Free Cash Flow Margin | 35.23 | 28.96 | 64.26 | 33.23 | 45.82 | |||||
Unlevered Free Cash Flow Margin | 38.74 | 32.36 | 67.73 | 36.66 | 49.46 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.49 | 0.54 | 0.54 | 0.55 | 0.57 | |||||
Fixed Assets Turnover | 11.84 | 13.09 | 12.58 | 12.51 | 12.11 | |||||
Receivables Turnover (Average Receivables) | 229.47 | - | - | 164.87 | 91.54 | |||||
Inventory Turnover (Average Inventory) | 4.54 | 5.48 | 5.22 | 2.31 | 2.37 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.71 | 0.84 | 0.49 | 0.51 | 0.65 | |||||
Quick Ratio | 0.54 | 0.67 | 0.38 | 0.39 | 0.52 | |||||
Operating Cash Flow to Current Liabilities | 0.98 | 0.96 | 0.82 | 1 | 1.01 | |||||
Days Sales Outstanding (Average Receivables) | 1.59 | - | - | 2.22 | 3.99 | |||||
Days Outstanding Inventory (Average Inventory) | 80.42 | 66.6 | 69.97 | 158.72 | 153.93 | |||||
Average Days Payable Outstanding | 23.64 | 28.14 | 32.94 | 93.43 | 104.22 | |||||
Cash Conversion Cycle (Average Days) | 58.37 | - | - | 67.51 | 53.7 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -1.75K | -680.09 | -751.66 | -1.14K | -744.76 | |||||
Total Debt / Total Capital | 106.07 | 117.24 | 115.35 | 109.62 | 115.51 | |||||
LT Debt/Equity | -1.68K | -640.43 | -719.54 | -1.07K | -699.3 | |||||
Long-Term Debt / Total Capital | 101.89 | 110.4 | 110.42 | 102.91 | 108.46 | |||||
Total Liabilities / Total Assets | 104.06 | 110.62 | 109.05 | 106.22 | 109.86 | |||||
EBIT / Interest Expense | 10.14 | 10.93 | 10.72 | 13.86 | 13.07 | |||||
EBITDA / Interest Expense | 10.35 | 11.14 | 10.96 | 14.11 | 13.3 | |||||
(EBITDA - Capex) / Interest Expense | 10.21 | 10.95 | 10.78 | 13.98 | 13.11 | |||||
Total Debt / EBITDA | 2.28 | 2.13 | 2.1 | 1.57 | 1.65 | |||||
Net Debt / EBITDA | 1.91 | 1.81 | 1.81 | 1.38 | 1.36 | |||||
Total Debt / (EBITDA - Capex) | 2.32 | 2.17 | 2.14 | 1.59 | 1.67 | |||||
Net Debt / (EBITDA - Capex) | 1.94 | 1.84 | 1.84 | 1.39 | 1.38 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.3 | -2 | -0.9 | -0.28 | -1.49 | |||||
Gross Profit, 1 Yr. Growth % | 3.35 | 1.75 | 0.51 | -0.94 | -1.17 | |||||
EBITDA, 1 Yr. Growth % | 3.53 | 2.06 | -0.46 | -2.06 | -1.34 | |||||
EBITA, 1 Yr. Growth % | 3.69 | 2.25 | -0.4 | -2.1 | -1.27 | |||||
EBIT, 1 Yr. Growth % | 3.72 | 2.25 | -0.85 | -2.18 | -1.24 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -44.43 | 132.89 | 41.05 | 38.55 | -38.33 | |||||
Net Income, 1 Yr. Growth % | -44.59 | 132.89 | 41.05 | 38.55 | -38.33 | |||||
Normalized Net Income, 1 Yr. Growth % | -52.46 | 55.27 | 50.72 | 0.03 | -2.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -44.35 | 138.71 | 43.21 | 43.25 | -37.07 | |||||
Accounts Receivable, 1 Yr. Growth % | -65.69 | - | - | 149.3 | 48.59 | |||||
Inventory, 1 Yr. Growth % | -39.27 | -1.17 | 2.97 | -11.11 | -0.93 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -22.81 | 3.54 | 2.74 | -2.12 | 5.75 | |||||
Total Assets, 1 Yr. Growth % | -16.64 | -6.5 | 4.37 | -8.8 | -0.45 | |||||
Tangible Book Value, 1 Yr. Growth % | 27.66 | 12.81 | 11.53 | -7.75 | -4.47 | |||||
Common Equity, 1 Yr. Growth % | -156.57 | 147.38 | -10.9 | -36.78 | 56.48 | |||||
Cash From Operations, 1 Yr. Growth % | 0.24 | -1.77 | 12.49 | -5.75 | 6.14 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.84 | 21.3 | -4.39 | -27.55 | 52.11 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -0.15 | -19.44 | 119.91 | -56.16 | 36.15 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -0.69 | -18.14 | 107.44 | -53.75 | 33.19 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.53 | 4.55 | 4.35 | 4.17 | 4 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.27 | -0.37 | -1.45 | -0.59 | -0.89 | |||||
Gross Profit, 2 Yr. CAGR % | 4.71 | 2.54 | 1.13 | -0.81 | -1.05 | |||||
EBITDA, 2 Yr. CAGR % | 5.5 | 3.25 | 1.25 | -1.41 | -1.37 | |||||
EBITA, 2 Yr. CAGR % | 5.64 | 3.43 | 1.38 | -1.4 | -1.35 | |||||
EBIT, 2 Yr. CAGR % | 5.54 | 3.45 | 1.16 | -1.61 | -1.38 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 38.09 | 13.76 | 81.24 | 39.79 | -7.56 | |||||
Net Income, 2 Yr. CAGR % | 38.35 | 13.59 | 81.24 | 39.79 | -7.56 | |||||
Normalized Net Income, 2 Yr. CAGR % | -34.32 | -13.65 | 54.74 | 15.56 | -0.87 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 38.13 | 15.25 | 84.89 | 43.23 | -5.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | -44.39 | 254.43 | - | -67.93 | 92.46 | |||||
Inventory, 2 Yr. CAGR % | -27.84 | -22.53 | 0.88 | -4.33 | -6.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -11.86 | -10.6 | 3.14 | 0.28 | 1.74 | |||||
Total Assets, 2 Yr. CAGR % | -10.44 | -11.72 | -1.21 | -2.43 | -4.72 | |||||
Tangible Book Value, 2 Yr. CAGR % | 28.05 | 20 | 12.17 | 1.43 | -6.13 | |||||
Common Equity, 2 Yr. CAGR % | -49.19 | 18.3 | 48.47 | -24.95 | -0.54 | |||||
Cash From Operations, 2 Yr. CAGR % | 3.56 | -0.77 | 5.12 | 2.97 | 0.02 | |||||
Capital Expenditures, 2 Yr. CAGR % | -17.12 | -5.8 | 7.69 | -16.77 | 4.98 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 10.74 | -9.91 | 33.73 | -9.81 | -22.62 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 9.26 | -9.47 | 30.86 | -9.02 | -21.4 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.59 | 4.04 | 4.45 | 4.26 | 4.08 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.46 | 1.48 | -0.55 | -1.06 | -0.89 | |||||
Gross Profit, 3 Yr. CAGR % | 4.61 | 3.71 | 1.86 | 8.49 | -0.93 | |||||
EBITDA, 3 Yr. CAGR % | 6.85 | 4.34 | 2 | 9.22 | -1.44 | |||||
EBITA, 3 Yr. CAGR % | 7.03 | 4.49 | 2.14 | 9.4 | -1.41 | |||||
EBIT, 3 Yr. CAGR % | 6.95 | 4.43 | 2 | 9.29 | -1.54 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -29.18 | 64.37 | 22.21 | 65.72 | 6.42 | |||||
Net Income, 3 Yr. CAGR % | -29.16 | 64.58 | 22.09 | 65.72 | 6.42 | |||||
Normalized Net Income, 3 Yr. CAGR % | -21.35 | -12.51 | 3.97 | 46.91 | 9.15 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -28.67 | 65.76 | 23.91 | 69.82 | 8.89 | |||||
Accounts Receivable, 3 Yr. CAGR % | -30.83 | 124.55 | - | - | -46.54 | |||||
Inventory, 3 Yr. CAGR % | -19.99 | -19.86 | -14.82 | -3.29 | -3.21 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -7.12 | -7 | -6.36 | 1.36 | 2.07 | |||||
Total Assets, 3 Yr. CAGR % | -10.68 | -9.14 | -6.65 | -3.81 | -1.78 | |||||
Tangible Book Value, 3 Yr. CAGR % | 92.21 | 22.75 | 17.11 | 5.09 | -0.57 | |||||
Common Equity, 3 Yr. CAGR % | -52.29 | -13.89 | 7.63 | 11.7 | -4.12 | |||||
Cash From Operations, 3 Yr. CAGR % | 0.06 | 1.75 | 3.46 | 1.36 | 4.01 | |||||
Capital Expenditures, 3 Yr. CAGR % | -10.79 | -5.9 | -5.33 | -5.64 | 1.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.63 | -0.41 | 21.3 | -2.67 | 3.38 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.93 | -0.77 | 19.35 | -2.59 | 3.24 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.47 | 3.91 | 4.14 | 4.35 | 4.17 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.77 | 1.2 | 0.88 | 0.65 | -0.68 | |||||
Gross Profit, 5 Yr. CAGR % | 3.74 | 3.39 | 3.2 | 6.96 | 5.45 | |||||
EBITDA, 5 Yr. CAGR % | 5.25 | 4.26 | 4.38 | 7.52 | 5.84 | |||||
EBITA, 5 Yr. CAGR % | 5.36 | 4.39 | 4.54 | 7.68 | 6 | |||||
EBIT, 5 Yr. CAGR % | 5.29 | 4.31 | 4.4 | 7.57 | 5.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -29.53 | -10.83 | 3.14 | 54.06 | 9.3 | |||||
Net Income, 5 Yr. CAGR % | -29.53 | -10.83 | 3.15 | 54.18 | 9.23 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.14 | -4.92 | 2.62 | 5.97 | 7.7 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -28.76 | -9.7 | 4.41 | 56.35 | 11.39 | |||||
Accounts Receivable, 5 Yr. CAGR % | -20.82 | 64.7 | - | 3.09 | 13.93 | |||||
Inventory, 5 Yr. CAGR % | -10.26 | -11.91 | -12.22 | -13.98 | -11.46 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -4.53 | -3.42 | -3.14 | -4.15 | -3.2 | |||||
Total Assets, 5 Yr. CAGR % | -2.96 | -3.08 | -7.01 | -6.52 | -5.88 | |||||
Tangible Book Value, 5 Yr. CAGR % | 33.21 | 56.01 | 54.96 | 13.73 | 7.2 | |||||
Common Equity, 5 Yr. CAGR % | -33.94 | -23.71 | -24.87 | -18.49 | 4.29 | |||||
Cash From Operations, 5 Yr. CAGR % | 17.05 | 10.99 | 2.05 | 2.24 | 2.07 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.21 | 0.6 | -3.81 | -10.41 | -1.33 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 5.97 | 8.48 | 12.54 | 2.29 | 4.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 6.28 | 8.54 | 12.45 | 1.81 | 4.05 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.42 | 7.7 | 5.06 | 4.05 | 4.12 |
- Stock Market
- Stocks
- MO Stock
- Financials Altria Group, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















